Hepatology
813 articles · 19 journals
Journals in this subcategory (19)
- Annals of Hepatology · Elsevier (90)
- Journal of Hepatology · Elsevier (80)
- Journal of Hepato-Biliary-Pancreatic Sciences · Wiley (74)
- HPB · Elsevier (72)
- Gastroenterology · Elsevier (64)
- Gastroenterología y Hepatología · Elsevier (63)
- Journal of Clinical and Experimental Hepatology · Elsevier (61)
- Clinics in Liver Disease · Elsevier (48)
- Cellular and Molecular Gastroenterology and Hepatology · Elsevier (45)
- Journal of Liver Transplantation · Elsevier (44)
- Journal of Gastroenterology and Hepatology (Australia) · Wiley (41)
- The Lancet Gastroenterology & Hepatology · Elsevier (37)
- Liver International · Wiley (34)
- Portal Hypertension and Cirrhosis · Wiley (28)
- Liver Research · Elsevier (19)
- Journal of Viral Hepatitis · Wiley (13)
- Current Hepatology Reports · Springer Nature (0)
- Egyptian Liver Journal · Springer Nature (0)
- Hepatology International · Springer Nature (0)
- The hepato-exposome axis: How endocrine disruptors hijack liver receptors to drive MASLD
- Baveno VIII – Advancing consensus in portal hypertension
- Regression of liver cirrhosis
- Fibrosis regression in chronic liver disease: The pathologist’s view
- From prevalence to programme: Liver fibrosis screening after LiverScreen
- Advancing functional cure for hepatitis B virus infection
- Mitochondrial NAD+ determines the metabolic capacity for liver regeneration
- Difficult diagnoses: Quando è notte, è notte per tutti
- Triple parallel TIPS for porto-sinusoidal vascular disorder with refractory hemorrhage: Portal hypertension, but not as we know it
- Agree to disagree: Increasing the impact of recommendations formulated through Delphi methodology
- Reply to: “Agree to disagree; increasing the impact of recommendations formulated through Delphi methodology”
- Single-nucleus and spatial transcriptomic analyses reveal intra-tissue heterogeneity of PNPLA3
- Reply to: “Single-nucleus and spatial transcriptomic analyses reveal intra-tissue heterogeneity of PNPLA3”
- Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy
- Reply to: “Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy”
- IFRD1: A promising target in human liver regeneration
- Reply to: “IFRD1: A promising target in human liver regeneration”
- Circulating FGF21 levels reflect liver disease risk and metabolic stress in the UK Biobank
- Rejection and perioperative management in liver transplantation following immune checkpoint inhibitor–based downstaging for hepatocellular carcinoma
- Reply to: “Rejection and perioperative management in liver transplantation following immune checkpoint inhibitor–based downstaging for hepatocellular carcinoma”: Revisiting rejection after immune checkpoint inhibitor exposure prior to liver transplantation for hepatocellular carcinoma
- Refining ACLF diagnosis: Beyond the scorecard
- Reply to: “Optimizing clinical adoption of large language models in hepatology: Toward terminological precision, multilingual adaptability, and interpretive literacy”
- Corrigendum to: “A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease” [J Hepatol 79 (2023) 394-402]
- Corrigendum to ‘TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma’ [J hepatol (2019) 71(4):731-741; doi: 10.1016/j.jhep.2019.05.015]
- Corrigendum to: “COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma” [J Hepatol (2022) 76(5):1138-1150; 10.1016/j.jhep.2022.01.009)
- Corrigendum to: “FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2” [J Hepatol (2023) 79(1):109-125; DOI: 10.1016/j.jhep.2023.02.036]
- Liver biopsy confirms precise and efficient correction of SERPINA1 after in vivo Base Editing in a Patient with Alpha-1 Antitrypsin Deficiency
- Seladelpar for alkaline phosphatase normalization in primary biliary cholangitis: The IDEAL phase III randomized controlled trial
- Senescence induces clonal failure of hepatocyte plasticity and reshapes regenerative lineages
- T cells and the bile duct: CD226-NECTIN2 as a druggable axis in immune-mediated cholangiopathy